Literature DB >> 18440513

Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage.

Malgorzata Jerzak1, Monika Kniotek, Jaroslaw Mrozek, Andrzej Górski, Wlodzimierz Baranowski.   

Abstract

OBJECTIVE: To evaluate the effect of sildenafil on peripheral natural killer (NK) cell activity in women with a history of recurrent miscarriage (RM).
DESIGN: Observational study.
SETTING: University teaching hospital. PATIENT(S): Thirty-eight nonpregnant women with a history of RM and 37 healthy women with previous successful pregnancy outcomes. INTERVENTION(S): Patients self-administered sildenafil suppositories (25 mg intravaginally, four times a day) for 36 days. MAIN OUTCOME MEASURE(S): Peripheral blood NK-cell activity before and after vaginal sildenafil therapy in the RM women was measured using flow cytometry. In addition, the influence of 10 microg and 400 ng sildenafil on NK-cell activity after in vitro culture were determined. Uterine artery blood flow and endometrial thickness were recorded using Doppler ultrasound with an intravaginal probe. RESULT(S): The NK-cell activity was significantly decreased after vaginal sildenafil therapy. Endometrial thickness was significantly increased after such therapy. CONCLUSION(S): Vaginal sildenafil might be an interesting therapeutic option before conception in women with histories of reproductive failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440513     DOI: 10.1016/j.fertnstert.2007.08.043

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Is there a relationship between phosphodiesterase type 5 inhibitors and biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis.

Authors:  Qing He; Bang-Hua Liao; Kai-Wen Xiao; Liang Zhou; Shi-Jian Feng; Hong Li; Kun-Jie Wang
Journal:  Int Urol Nephrol       Date:  2018-09-19       Impact factor: 2.370

2.  [Recurrence-free survival after radical prostatectomy and PDE-5 inhibitor intake].

Authors:  L Hofer; J P Radtke; C Rapp; S Pahernik; D Teber; M Hohenfellner; B Hadaschik
Journal:  Urologe A       Date:  2017-04       Impact factor: 0.639

Review 3.  Nitric oxide synthases and tubal ectopic pregnancies induced by Chlamydia infection: basic and clinical insights.

Authors:  Ruijin Shao; Sean X Zhang; Birgitta Weijdegård; Shien Zou; Emil Egecioglu; Anders Norström; Mats Brännström; Håkan Billig
Journal:  Mol Hum Reprod       Date:  2010-07-20       Impact factor: 4.025

4.  Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.

Authors:  Stacy Loeb; Yasin Folkvaljon; David Robinson; Thorsten Schlomm; Hans Garmo; Pär Stattin
Journal:  Eur Urol       Date:  2015-12-29       Impact factor: 20.096

5.  Sildenafil citrate and uteroplacental perfusion in fetal growth restriction.

Authors:  Marzieh Vahid Dastjerdi; Sayedehafagh Hosseini; Leila Bayani
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

6.  Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial.

Authors:  Razieh Dehghani Firouzabadi; Robab Davar; Farzaneh Hojjat; Mohamad Mahdavi
Journal:  Iran J Reprod Med       Date:  2013-02

Review 7.  Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy.

Authors:  Su Jin Kim; Ju Ho Kim; Hyun-Kyung Chang; Khae Hawn Kim
Journal:  J Exerc Rehabil       Date:  2016-06-30

Review 8.  Phosphodiesterase type 5 and cancers: progress and challenges.

Authors:  Ines Barone; Cinzia Giordano; Daniela Bonofiglio; Sebastiano Andò; Stefania Catalano
Journal:  Oncotarget       Date:  2017-10-12

Review 9.  Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients.

Authors:  Monika Kniotek; Agnieszka Boguska
Journal:  J Immunol Res       Date:  2017-02-20       Impact factor: 4.818

10.  Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting.

Authors:  Heba M Aboud; Amira H Hassan; Adel A Ali; Abdel-Razik H Abdel-Razik
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.